Irinotecan bulk supplier for pharma manufacturers

Irinotecan 100 mg/5 mL, 300 mg/15 mL Suppliers & Bulk Manufacturers

Available Forms: Injection/Infusion Solution

Available Strengths: 100 mg/5 mL, 300 mg/15 mL

Reference Brands: Camptosar® (US & EU)

Irinotecan is a chemotherapy drug used to treat cancers like colorectal, ovarian, and lung cancer. Available as an intravenous solution in 100 mg/5 mL and 300 mg/15 mL strengths, it is marketed as Camptosar® by Pfizer, with generic versions like Irinotecan Accord and Irinotecan Mylan. Widely sourced by B2B pharmaceutical wholesalers in the US and EU, it ensures reliable supply, GMP compliance, and competitive pricing for oncology centers.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Irinotecan is an essential chemotherapy drug used in the treatment of various cancers, including colorectal, ovarian, and lung cancer. As a topoisomerase I inhibitor, it blocks DNA replication in cancer cells, preventing tumor growth. Available in intravenous (IV) solution forms, it is commonly provided in 100 mg/5 mL and 300 mg/15 mL strengths. Marketed under the brand Camptosar® by Pfizer, as well as in generic versions such as Irinotecan Accord and Irinotecan Mylan, it is widely sourced by B2B pharmaceutical wholesalers across the US and EU, ensuring reliable supply, GMP compliance, and competitive pricing for oncology centers.

Irinotecan — third party manufacturing & bulk supply

Irinotecan 100 mg/5 mL, 300 mg/15 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Irinotecan is supplied as Injection/Infusion Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Irinotecan listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Irinotecan →

Back to Listing

Frequently Asked Questions

Irinotecan is listed as Injection/Infusion Solution in 100 mg/5 mL, 300 mg/15 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Irinotecan is referenced against Camptosar® (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.